(FISI) Financial Institutions - Overview
Sector: Financial ServicesIndustry: Banks - Regional | Exchange NASDAQ (USA) | Currency USD | Market Cap: 629m | Total Return 26.2% in 12m
Stock: Banking, Loans, Mortgages, Investments, Wealth
Total Rating 55
Risk 64
Buy Signal -0.04
| Risk 5d forecast | |
|---|---|
| Volatility | 33.2% |
| Relative Tail Risk | -19.9% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.78 |
| Alpha | 11.22 |
| Character TTM | |
|---|---|
| Beta | 1.140 |
| Beta Downside | 1.302 |
| Drawdowns 3y | |
|---|---|
| Max DD | 27.83% |
| CAGR/Max DD | 0.85 |
EPS (Earnings per Share)
Revenue
Description: FISI Financial Institutions February 28, 2026
Financial Institutions, Inc. (NASDAQ: FISI) operates a network of community banks in New York, offering a full suite of retail and commercial banking products-including checking, savings, money-market accounts, CDs, and a range of loan solutions from consumer auto financing to commercial mortgages-as well as wealth-management and investment-advisory services. The firm also runs a REIT that holds residential mortgages and commercial real-estate loans.
In its most recent quarter (Q4 2025), FISI reported a net interest margin of 3.45 % and a 5.2 % year-over-year increase in total loan balances to $2.84 billion, while maintaining a Common Equity Tier 1 (CET1) capital ratio of 12.8 %, well above the regulatory minimum. Deposits grew 4.1 % to $3.12 billion, supporting the bank’s ability to fund loan growth without relying heavily on wholesale funding.
The regional-bank sector remains sensitive to the Federal Reserve’s policy stance; the recent 0.25 % rate hike in January 2026 has compressed margins for low-yielding loan portfolios but also improves net interest income on newly originated loans. Additionally, New York’s commercial-real-estate market is stabilizing after a 2023-2024 slowdown, providing a modest tailwind for FISI’s REIT holdings and commercial-loan pipeline.
For a deeper dive, you may want to review ValueRay’s detailed analysis of FISI.
Headlines to watch out for
- Net interest income growth hinges on interest rate environment
- Loan portfolio quality impacts credit loss provisions
- Regulatory compliance costs affect profitability
- Wealth management fees drive non-interest income
- Local economic conditions influence loan demand
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: 74.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.00 > 0.02 and ΔFCF/TA -0.93 > 1.0 |
| NWC/Revenue: 4.23% < 20% (prev -1.94k%; Δ 1.94k% < -1%) |
| CFO/TA 0.00 > 3% & CFO 18.8m > Net Income 74.9m |
| Net Debt (225.5m) to EBITDA (97.1m): 2.32 < 3 |
| Current Ratio: 1.17 > 1.5 & < 3 |
| Outstanding Shares: last quarter (20.3m) vs 12m ago 23.78% < -2% |
| Gross Margin: 61.61% > 18% (prev 0.33%; Δ 6.13k% > 0.5%) |
| Asset Turnover: 6.08% > 50% (prev 4.32%; Δ 1.77% > 0%) |
| Interest Coverage Ratio: 0.51 > 6 (EBITDA TTM 97.1m / Interest Expense TTM 133.0m) |
Altman Z'' 0.39
| A: 0.00 (Total Current Assets 108.8m - Total Current Liabilities 92.8m) / Total Assets 6.27b |
| B: 0.07 (Retained Earnings 437.1m / Total Assets 6.27b) |
| C: 0.01 (EBIT TTM 67.4m / Avg Total Assets 6.20b) |
| D: 0.07 (Book Value of Equity 404.3m / Total Liabilities 5.65b) |
| Altman-Z'' Score: 0.39 = B |
Beneish M -3.34
| DSRI: 0.74 (Receivables 25.1m/23.7m, Revenue 377.0m/264.2m) |
| GMI: 0.54 (GM 61.61% / 33.33%) |
| AQI: 1.00 (AQ_t 0.97 / AQ_t-1 0.97) |
| SGI: 1.43 (Revenue 377.0m / 264.2m) |
| TATA: 0.01 (NI 74.9m - CFO 18.8m) / TA 6.27b) |
| Beneish M-Score: -3.34 (Cap -4..+1) = AA |
What is the price of FISI shares?
As of March 28, 2026, the stock is trading at USD 30.89 with a total of 81,280 shares traded.
Over the past week, the price has changed by +0.98%, over one month by -0.51%, over three months by -1.20% and over the past year by +26.24%.
Over the past week, the price has changed by +0.98%, over one month by -0.51%, over three months by -1.20% and over the past year by +26.24%.
Is FISI a buy, sell or hold?
Financial Institutions has received a consensus analysts rating of 4.00.
Therefore, it is recommended to buy FISI.
- StrongBuy: 0
- Buy: 2
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the FISI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 37 | 19.8% |
| Analysts Target Price | 37 | 19.8% |
FISI Fundamental Data Overview March 27, 2026
P/E Trailing = 8.6565
P/E Forward = 11.274
P/S = 2.6963
P/B = 0.9821
P/EG = 1.4095
Revenue TTM = 377.0m USD
EBIT TTM = 67.4m USD
EBITDA TTM = 97.1m USD
Long Term Debt = 193.7m USD (from longTermDebt, last quarter)
Short Term Debt = 112.1m USD (from shortTermDebt, last quarter)
Debt = 334.2m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 225.5m USD (from netDebt column, last quarter)
Enterprise Value = -107.4m USD (629.1m + Debt 334.2m - CCE 1.07b)
Interest Coverage Ratio = 0.51 (Ebit TTM 67.4m / Interest Expense TTM 133.0m)
EV/FCF = -6.90x (Enterprise Value -107.4m / FCF TTM 15.6m)
FCF Yield = -14.49% (FCF TTM 15.6m / Enterprise Value -107.4m)
FCF Margin = 4.13% (FCF TTM 15.6m / Revenue TTM 377.0m)
Net Margin = 19.86% (Net Income TTM 74.9m / Revenue TTM 377.0m)
Gross Margin = 61.61% ((Revenue TTM 377.0m - Cost of Revenue TTM 144.7m) / Revenue TTM)
Gross Margin QoQ = 62.88% (prev 63.11%)
Tobins Q-Ratio = -0.02 (set to none) (Enterprise Value -107.4m / Total Assets 6.27b)
Interest Expense / Debt = 9.71% (Interest Expense 32.4m / Debt 334.2m)
Taxrate = 16.74% (4.02m / 24.0m)
NOPAT = 56.1m (EBIT 67.4m * (1 - 16.74%))
Current Ratio = 1.17 (Total Current Assets 108.8m / Total Current Liabilities 92.8m)
Debt / Equity = 0.53 (Debt 334.2m / totalStockholderEquity, last quarter 628.9m)
Debt / EBITDA = 2.32 (Net Debt 225.5m / EBITDA 97.1m)
Debt / FCF = 14.48 (Net Debt 225.5m / FCF TTM 15.6m)
Total Stockholder Equity = 610.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 1.21% (Net Income 74.9m / Total Assets 6.27b)
RoE = 12.26% (Net Income TTM 74.9m / Total Stockholder Equity 610.5m)
RoCE = 8.38% (EBIT 67.4m / Capital Employed (Equity 610.5m + L.T.Debt 193.7m))
RoIC = 6.92% (NOPAT 56.1m / Invested Capital 810.4m)
WACC = 9.33% (E(629.1m)/V(963.3m) * Re(9.99%) + D(334.2m)/V(963.3m) * Rd(9.71%) * (1-Tc(0.17)))
Discount Rate = 9.99% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 14.45%
[DCF] Terminal Value 64.87% ; FCFF base≈38.2m ; Y1≈25.1m ; Y5≈11.5m
[DCF] Fair Price = N/A (negative equity: EV 184.3m - Net Debt 225.5m = -41.2m; debt exceeds intrinsic value)
EPS Correlation: -2.89 | EPS CAGR: 0.85% | SUE: 0.08 | # QB: 0
Revenue Correlation: -11.50 | Revenue CAGR: 17.42% | SUE: 2.30 | # QB: 1
EPS next Quarter (2026-06-30): EPS=0.94 | Chg7d=+0.045 | Chg30d=+0.015 | Revisions Net=+0 | Analysts=2
EPS current Year (2026-12-31): EPS=3.92 | Chg7d=+0.075 | Chg30d=+0.050 | Revisions Net=+1 | Growth EPS=+8.4% | Growth Revenue=+5.7%
EPS next Year (2027-12-31): EPS=4.15 | Chg7d=+0.075 | Chg30d=+0.050 | Revisions Net=+1 | Growth EPS=+6.0% | Growth Revenue=+4.7%
[Analyst] Revisions Ratio: +0.00 (1 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -1.6% (Discount Rate 10.0% - Earnings Yield 11.6%)
[Growth] Growth Spread = +7.9% (Analyst 6.3% - Implied -1.6%)
P/E Forward = 11.274
P/S = 2.6963
P/B = 0.9821
P/EG = 1.4095
Revenue TTM = 377.0m USD
EBIT TTM = 67.4m USD
EBITDA TTM = 97.1m USD
Long Term Debt = 193.7m USD (from longTermDebt, last quarter)
Short Term Debt = 112.1m USD (from shortTermDebt, last quarter)
Debt = 334.2m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 225.5m USD (from netDebt column, last quarter)
Enterprise Value = -107.4m USD (629.1m + Debt 334.2m - CCE 1.07b)
Interest Coverage Ratio = 0.51 (Ebit TTM 67.4m / Interest Expense TTM 133.0m)
EV/FCF = -6.90x (Enterprise Value -107.4m / FCF TTM 15.6m)
FCF Yield = -14.49% (FCF TTM 15.6m / Enterprise Value -107.4m)
FCF Margin = 4.13% (FCF TTM 15.6m / Revenue TTM 377.0m)
Net Margin = 19.86% (Net Income TTM 74.9m / Revenue TTM 377.0m)
Gross Margin = 61.61% ((Revenue TTM 377.0m - Cost of Revenue TTM 144.7m) / Revenue TTM)
Gross Margin QoQ = 62.88% (prev 63.11%)
Tobins Q-Ratio = -0.02 (set to none) (Enterprise Value -107.4m / Total Assets 6.27b)
Interest Expense / Debt = 9.71% (Interest Expense 32.4m / Debt 334.2m)
Taxrate = 16.74% (4.02m / 24.0m)
NOPAT = 56.1m (EBIT 67.4m * (1 - 16.74%))
Current Ratio = 1.17 (Total Current Assets 108.8m / Total Current Liabilities 92.8m)
Debt / Equity = 0.53 (Debt 334.2m / totalStockholderEquity, last quarter 628.9m)
Debt / EBITDA = 2.32 (Net Debt 225.5m / EBITDA 97.1m)
Debt / FCF = 14.48 (Net Debt 225.5m / FCF TTM 15.6m)
Total Stockholder Equity = 610.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 1.21% (Net Income 74.9m / Total Assets 6.27b)
RoE = 12.26% (Net Income TTM 74.9m / Total Stockholder Equity 610.5m)
RoCE = 8.38% (EBIT 67.4m / Capital Employed (Equity 610.5m + L.T.Debt 193.7m))
RoIC = 6.92% (NOPAT 56.1m / Invested Capital 810.4m)
WACC = 9.33% (E(629.1m)/V(963.3m) * Re(9.99%) + D(334.2m)/V(963.3m) * Rd(9.71%) * (1-Tc(0.17)))
Discount Rate = 9.99% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 14.45%
[DCF] Terminal Value 64.87% ; FCFF base≈38.2m ; Y1≈25.1m ; Y5≈11.5m
[DCF] Fair Price = N/A (negative equity: EV 184.3m - Net Debt 225.5m = -41.2m; debt exceeds intrinsic value)
EPS Correlation: -2.89 | EPS CAGR: 0.85% | SUE: 0.08 | # QB: 0
Revenue Correlation: -11.50 | Revenue CAGR: 17.42% | SUE: 2.30 | # QB: 1
EPS next Quarter (2026-06-30): EPS=0.94 | Chg7d=+0.045 | Chg30d=+0.015 | Revisions Net=+0 | Analysts=2
EPS current Year (2026-12-31): EPS=3.92 | Chg7d=+0.075 | Chg30d=+0.050 | Revisions Net=+1 | Growth EPS=+8.4% | Growth Revenue=+5.7%
EPS next Year (2027-12-31): EPS=4.15 | Chg7d=+0.075 | Chg30d=+0.050 | Revisions Net=+1 | Growth EPS=+6.0% | Growth Revenue=+4.7%
[Analyst] Revisions Ratio: +0.00 (1 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -1.6% (Discount Rate 10.0% - Earnings Yield 11.6%)
[Growth] Growth Spread = +7.9% (Analyst 6.3% - Implied -1.6%)